MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. — Investor Relations & Filings
About MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
Mabwell (Shanghai) Bioscience Co., Ltd. is a biopharmaceutical enterprise focused on the discovery, development, and commercialization of therapeutic antibodies and innovative biologics. The company maintains an integrated R&D and manufacturing platform covering the full drug lifecycle, from target discovery and preclinical research to clinical development and commercial production. Its therapeutic pipeline addresses critical needs in oncology, autoimmune diseases, metabolic disorders, ophthalmology, and infectious diseases. Mabwell leverages proprietary technology platforms, including antibody-drug conjugates (ADCs), bispecific antibodies, and high-throughput screening, to develop a diverse portfolio of novel drug candidates and biosimilars. The organization is committed to delivering high-quality, accessible therapeutic solutions through its end-to-end biotechnological capabilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 迈威生物2026年第一季度报告 | 2026-04-28 | Chinese | |
| 迈威生物关于境外上市外资股（H股）公开发行价格的公告 | 2026-04-24 | Chinese | |
| 迈威生物关于2025年年度股东会增加会议地址的公告 | 2026-04-23 | Chinese | |
| 迈威生物关于刊发H股招股说明书、H股发行价格区间及H股香港公开发售等事宜的公告 | 2026-04-19 | Chinese | |
| 迈威生物自愿披露关于迈卫健?注射液增加适应症补充申请获得受理的公告 | 2026-04-15 | Chinese | |
| 迈威生物自愿披露关于注射用6MW5311临床试验申请获得国家药品监督管理局受理的公告 | 2026-04-15 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44579773 | 迈威生物2026年第一季度报告 | 2026-04-28 | Chinese | ||
| 44579763 | 迈威生物关于境外上市外资股（H股）公开发行价格的公告 | 2026-04-24 | Chinese | ||
| 44579753 | 迈威生物关于2025年年度股东会增加会议地址的公告 | 2026-04-23 | Chinese | ||
| 44579751 | 迈威生物关于刊发H股招股说明书、H股发行价格区间及H股香港公开发售等事宜的公告 | 2026-04-19 | Chinese | ||
| 44579750 | 迈威生物自愿披露关于迈卫健?注射液增加适应症补充申请获得受理的公告 | 2026-04-15 | Chinese | ||
| 44579745 | 迈威生物自愿披露关于注射用6MW5311临床试验申请获得国家药品监督管理局受理的公告 | 2026-04-15 | Chinese | ||
| 44579742 | 迈威生物第二届董事会第三十次会议决议公告 | 2026-04-07 | Chinese | ||
| 44579731 | 公司章程（草案） | 2026-04-07 | Chinese | ||
| 44579717 | 董事会议事规则（草案） | 2026-04-07 | Chinese | ||
| 44579707 | 股东提名人选参选董事的程序（草案） | 2026-04-07 | Chinese | ||
| 44579699 | 董事会审计委员会工作细则（草案） | 2026-04-07 | Chinese | ||
| 44579685 | 对外担保管理制度（草案） | 2026-04-07 | Chinese | ||
| 44579678 | 独立董事工作制度（草案） | 2026-04-07 | Chinese | ||
| 44579669 | 董事会提名委员会工作细则》草案） | 2026-04-07 | Chinese | ||
| 44579661 | 董事会环境、社会及管治（ESG）委员会工作细则（草案） | 2026-04-07 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58111/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58111 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58111 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58111 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58111}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. (id: 58111)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.